indoprofen has been researched along with Lupus Erythematosus, Systemic in 3 studies
Indoprofen: A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p21)
indoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(1-oxo-1,3-dihydroisoindol-2-yl)phenyl group. Initially used as an anti-inflammatory and analgesic, it was withdrawn from the market due to causing severe gastrointestinal bleeding. It has been subsequently found to increase production of the survival motor neuron protein.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this paper we report on the positive identification of an indoprofen-induced severe pancytopenia in a multi-drug-treated patient with active systemic lupus erythematosus by use of a drug-specific lymphocyte transformation test." | 3.67 | Indoprofen-induced aplastic anemia in active connective tissue disease detected by drug-specific lymphocyte transformation. ( Berg, PA; Daniel, PT; Saal, JG, 1986) |
| "We report of a 22-year-old woman with systemic lupus erythematosus (SLE) who was admitted to the intensive care unit (ICU) because of obtundation and a febrile illness." | 1.31 | Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. ( Bellmann, R; Obermoser, G; Pfausler, B; Schmutzhard, E; Sepp, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obermoser, G | 1 |
| Bellmann, R | 1 |
| Pfausler, B | 1 |
| Schmutzhard, E | 1 |
| Sepp, N | 1 |
| Saal, JG | 2 |
| Daniel, PT | 2 |
| Berg, PA | 2 |
| Waller, HD | 1 |
3 other studies available for indoprofen and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings.
Topics: Adult; Cyclooxygenase Inhibitors; Female; Humans; Indoprofen; Lupus Erythematosus, Systemic; Magneti | 2002 |
Indoprofen-induced aplastic anaemia in systemic lupus, diagnosed by lymphocyte transformation tests.
Topics: Adult; Anemia, Aplastic; Female; Humans; Indoprofen; Lupus Erythematosus, Systemic; Lymphocyte Activ | 1985 |
Indoprofen-induced aplastic anemia in active connective tissue disease detected by drug-specific lymphocyte transformation.
Topics: Adult; Agranulocytosis; Anemia, Aplastic; Diagnosis, Differential; Drug Hypersensitivity; Drug Thera | 1986 |